HealthcareServices

Global Plasmid DNA Manufacturing Market 2026–2030: Forecast Insights for Business Planning

March 5, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the plasmid dna manufacturing market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Plasmid DNA Manufacturing Market expected to reach by 2030?

The plasmid dna manufacturing market has experienced significant expansion in recent years. Projections indicate it will grow from $2.89 billion in 2025 to $3.58 billion in 2026, achieving a compound annual growth rate (CAGR) of 23.6%. The market’s historical development is attributable to several factors, including the increasing use of plasmid dna in research applications, the expansion of molecular cloning activities, the growth of preclinical therapeutic development, rising investments in biotechnology research, and improved bacterial fermentation techniques.

The plasmid dna manufacturing market size is predicted to undergo significant expansion in the upcoming years. It is forecasted to attain a value of $7.64 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 20.9%. This projected growth is driven by elements such as the rising demand for dna-based vaccines, escalating investments in gene and cell therapy pipelines, the expansion of commercial-scale plasmid manufacturing operations, an increasing emphasis on regulatory-compliant production, and the wider adoption of advanced purification technologies. Notable trends expected during the forecast timeframe encompass an increasing requirement for gmp-grade plasmid dna production, the growing implementation of automated bioprocessing systems, the expanding utilization of plasmid dna in gene therapy applications, the enlargement of large-scale manufacturing capacities, and a heightened focus on producing high-purity dna.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15895&type=smp

What Drivers Are Driving Adoption Within The Plasmid DNA Manufacturing Market?

The increasing adoption of gene therapy is projected to boost the expansion of the plasmid DNA manufacturing market. Gene therapy is defined as a medical approach that entails altering or influencing an individual’s genes to address or avert illnesses. Its increasing prominence stems from progress in genetic engineering technologies, rising research and development investments, positive clinical trial outcomes, and the rising incidence of genetic conditions, all underscoring its capacity to offer lasting or permanent treatments. Plasmid DNA production is crucial for gene therapy because it creates the vectors required to introduce therapeutic genes into cells, thereby aiding in the treatment of genetic disorders. As an illustration, the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, reported that gene therapies in Phase III clinical trials saw a 10% increase in Q3 2023, marking the first quarterly rise since Q3 2022. Consequently, the expanding acceptance of gene therapy is propelling the growth of the plasmid DNA manufacturing market.

How Is The Plasmid DNA Manufacturing Market Organized Into Various Segments?

The plasmid dna manufacturing market covered in this report is segmented –

1) By Grade: Research And Development Grade, Good Manufacturing Practice (GMP) Grade

2) By Development Phase: Pre-Clinical Therapeutics, Clinical Therapeutics, Marketed Therapeutics

3) By Disease: Infectious Disease, Cancer, Genetic Disorder, Other Diseases

4) By Application: Deoxyribonucleic Acid (DNA) Vaccines, Cell And Gene Therapy, Immunotherapy, Other Applications

Subsegments:

1) By Research And Development Grade: Small-scale Plasmid DNA Production, Preclinical Research Plasmid DNA

2) By Good Manufacturing Practice (GMP) Grade: Clinical Trial Material Production, Commercial-Scale Plasmid DNA Production

Which Trends Are Influencing The Performance And Direction Of The Plasmid DNA Manufacturing Market?

Major companies operating in the plasmid DNA manufacturing market are actively developing sophisticated bioprocessing technologies to enhance the efficiency, scalability, and quality of plasmid DNA production. These innovations aim to streamline the manufacturing process, reduce production costs, and ensure that the plasmid DNA meets stringent regulatory standards for therapeutic applications. For instance, in January 2023, Charles River Laboratories, a US-based pharmaceutical company, launched the eXpDNA platform, designed for the efficient production and purification of high-quality plasmid DNA. This platform integrates advanced bioprocessing technologies, scalable production methods, and rigorous quality control measures to produce plasmid DNA that meets the stringent requirements for therapeutic and clinical applications. The eXpDNA platform is used extensively in gene therapy, DNA vaccine development, and other biopharmaceutical applications that demand high yield, purity, and consistency.

Who Are The Primary Competitors In The Global Plasmid DNA Manufacturing Market?

Major companies operating in the plasmid dna manufacturing market are Thermo Fisher Scientific Inc., Eurofins Genomics LLC, Catalent Inc., Charles River Laboratories, Recipharm AB, Kaneka Corp., Genscript Biotech Corporation, Aldevron LLC, Genewiz, OriGene Technologies, Celonic AG, Creative Biogene, Cellectis, Synbio Technologies, VectorBuilder Inc., Altogen Biosystems, Andelyn Biosciences, AGC Biologics, VGXI, GeneCopoeia, PlasmidFactory GmbH & Co. KG, Akron Biotech, PackGene Biotech Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/plasmid-dna-manufacturing-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Plasmid DNA Manufacturing Market?

North America was the largest region in the plasmid DNA manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasmid dna manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Plasmid DNA Manufacturing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15895&type=smp

Browse Through More Reports Similar to the Global Plasmid DNA Manufacturing Market 2026, By The Business Research Company

Dna Test Kits Market Report 2026

https://www.thebusinessresearchcompany.com/report/dna-test-kits-global-market-report

Recombinant Dna Technology Market Report 2026

https://www.thebusinessresearchcompany.com/report/recombinant-dna-technology-global-market-report

Bacterial And Plasmid Vector Market Report 2026

https://www.thebusinessresearchcompany.com/report/bacterial-and-plasmid-vector-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795